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Measuring outcomes in trials of interventions
for people who self-harm: qualitative study of
service users’ views
Christabel Owens, Fiona Fox, Sabi Redwood, Rosemary Davies, Lisa Foote, Naomi Salisbury,
Salena Williams, Lucy Biddle and Kyla Thomas
Background
Patients often have very different ideas from clinicians about
what they want treatments to achieve. Their views on what
outcomes are important are not always reflected in trials.
Aims
To elicit the views of people who self-harm on the most com-
monly used outcome measures and to identify the outcomes
that matter to them.
Method
We conducted in-depth interviews with 18 people with histories
of self-harm, recruited from hospital and community settings.
We conducted thematic analysis using a framework approach
and used visual mapping to arrive at our final analysis and
interpretation.
Results
Participants’ accounts contained a number of challenges to the
validity and meaningfulness of current trial outcome measures.
Five broad issues emerged: (a) relationship between frequency
and severity of self-harm; (b) behavioural substitution; (b) self-
management skills; (d) the role of self-harm as survival tool and
affect regulator, and (e) strategic self-presentation. We show
how these affect the visibility and measurability of commonly
used outcomes. The outcomes that mattered to participants
focused on positive achievements in three domains: (a) general
functioning and activities of everyday living; (b) social participa-
tion, and (c) engagement with services. Participants
conceptualised these as both measures and means of sustained
improvement.
Conclusions
Our findings suggest that current self-harm trial science rests on
flawed assumptions about the relationship between mental
states and behaviours and about our ability to measure both.
Greater understanding of the outcomes that matter to people
who self-harm is needed to inform both intervention develop-
ment and trial design.
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Self-harm refers to a range of behaviours with a non-fatal outcome
in which an individual intentionally causes harm to themselves,
irrespective of the motivation or degree of suicidal intent.1 It is
the strongest risk factor for completed suicide, especially when
repeated,2,3 and places a heavy cost burden on healthcare
systems.4 It is one of the most common reasons for accident and
emergency (A&E) visits, accounting for over 200 000 visits every
year in England alone.5 However, most self-harm occurs in
private and does not come to the attention of clinical services, so
its true prevalence is unknown.6 The national suicide prevention
strategy for England identifies the management and reduction of
self-harm as a priority area for action and a key progress indicator.7
Problems with outcome measurement
People’s reasons for self-harming are wide-ranging and complex,8,9
and the interventions offered to those who self-harm are diverse.
They include drug treatments targeting underlying psychiatric
conditions and psychosocial interventions mainly targeting cogni-
tions and behaviour, but despite huge research effort there
remains little evidence to guide clinical decision-making. A recent
series of Cochrane reviews found no evidence of effectiveness for
any pharmacological treatments in adults,10 only moderate evidence
for some psychosocial interventions in adults,11 and no compelling
evidence for either in children and adolescents.12 These results raise
questions about whether it is the interventions that are flawed or
the trial science. Reviews repeatedly point to small participant
numbers as a contributory factor, but an alternative explanation
may lie in the selection of outcomes and the means whereby they
are measured.13
The most commonly used primary outcome is reduction in
repetition of self-harm, which is frequently measured by way of a
proxy, namely hospital presentations. Psychometric scales of
depression, anxiety, hopelessness and suicidal ideation also feature
regularly. Other outcomes selected for measurement are heteroge-
neous, including such diverse measures as fear, aggression,
alcohol use, ‘emotional clarity’ and ‘trauma-related guilt cogni-
tions’.10–12 The variety of clinical and non-clinical problems experi-
enced by people who self-harm may make it necessary for trials to
measure a number of different outcomes.14 Nonetheless, single
small trials have been known to include as many as ten different
measures, some of which appear to have no strong theoretical
basis. Such practice places a heavy burden on trial participants,
increasing the likelihood of attrition. More seriously, it suggests
lack of clarity about what interventions are designed to do and
lack of consensus within the field about what outcomes are import-
ant. Without the latter, it is difficult to develop interventions that
adequately address the needs of this population.
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The importance of patient perspectives
Problems of heterogeneity in the selection of outcomes for measure-
ment has long been recognised, and in many clinical specialities
has led to the development of core outcome sets.15 These establish
an agreed set of outcomes to be measured and reported as a
minimum in all trials of interventions for a given condition, and
are widely advocated as a way of simplifying and standardising
trial design and improving comparability of results.16–18 They
need to be based on consensus between all stakeholders, including
patients. Patients often have very different ideas from clinicians
about what they want treatments to achieve, and their views on
what outcomes are important are not always reflected in trials.19
When trials measure outcomes that are of interest to clinicians
and scientists but do not take account of patient perspectives,
the resulting evidence lacks relevance and fails to support well-
informed shared decision-making.20
Little is known about what outcomes matter to people who self-
harm. As part of a broader investigation of challenges in the conduct
of self-harm research and as a prelude to the development of a core
outcome set, we asked people with histories of self-harming behav-
iour for their views on some of the outcomemeasures in current use,
and on the sort of changes they would want interventions to bring
about for them.
Method
Design
We conducted a qualitative interview study in order to elicit the
views of people with lived experience of self-harm. All aspects of
the study were informed by a patient and public involvement
process.21 At an initial stakeholder workshop, self-harm service-
user representatives identified the need for more meaningful trial
outcomes as a research priority. This was followed by a series of
publicly advertised discussion groups (co-ordinated by R.D., L.F.
and N.S.) to refine the focus and study design. Two service-user
representatives (L.F. and N.S.) sat on the project advisory group.
Participants and recruitment
Participants were eligible for inclusion if they were aged 18 or over
and had attended A&E for self-harm within the past 3 years. We
recruited participants through both hospital and community set-
tings in order to capture as wide a range of experiences as possible.
Members of the liaison psychiatry team in the A&E department of a
large city hospital identified eligible patients, introduced the study
and asked whether they were willing for their contact details to be
passed to a researcher. A community-based, voluntary-sector self-
harm support service in the same city displayed an advert for the
study in its premises and on its website, and sent information to
all members of its mailing list. The advert was also disseminated
via Twitter. Those who responded were sent a letter, information
sheet, reply slip and prepaid envelope.
Data collection
Participants took part in a single interview, with the option of
face-to-face, telephone or email, and all provided written consent.
Face-to-face and telephone interviews lasted up to an hour and
were audio-recorded and transcribed. Transcripts of email inter-
views were generated automatically. All interviews were conducted
by F.F. and followed the same semi-structured topic guide, designed
to explore participants’ views on the outcome measures currently
used in trials of interventions for self-harm, what ‘improvement’
would mean to them and how it might be measured (see supple-
mentary data 1, available at https://doi.org/10.1192/bjo.2019.93).
Analysis
Transcripts were anonymised and analysed using thematic analysis,
in combination with a framework approach.22–24 Two members of
the team (C.O. and F.F.) read all the transcripts closely in order to
become familiar with the data and generate possible codes. These
included some a priori codes reflecting interview questions and
others resulting from inductive or open coding. These were dis-
cussed with members of the wider team and then applied to the
complete data-set, first using NVivo software to code transcripts,
and later charting the material using Excel to create a matrix of
rows (participants) and columns (themes and subthemes) and
populating it with summarised data segments and interpretive
notes (see supplementary data 2).24 This framework method pro-
vides a ‘viewing platform’ from which to survey the entire coded
data-set, enabling comparisons within and across cases (partici-
pants) and identification of higher-level conceptual themes.23 The
final stage involved visual mapping of themes and subthemes,
during which they were further refined, and working via a series
of iterations towards a final analytic narrative.
Ethics
Ethical approval was granted by South West – Frenchay NHS
Research Ethics Committee (Ref: 16/SW/0296). All participants
gave written informed consent to interview.
Results
We recruited 18 participants: 8 from a hospital A&E department
and 10 through community settings. There were 14 women and 4
men. The average age was 27 years (range 19–46; hospital average,
24 years; community average, 29 years). The majority of partici-
pants in both groups had attended A&E for self-harm more than
once during the past 3 years (hospital 6/8; community 7/10). Two
of the community participants reported that they were no longer
self-harming, after having done so for many years. Participant char-
acteristics are shown in Table 1. We present our findings under
two broad headings: challenges to the validity of current outcome
measures, and differences in the conceptualisation of outcomes
and measures.
Challenges to the validity of current outcome measures
‘Obviously, I guess the best outcome would be that people stop
self-harming.’ (Participant 02)
‘I haven’t self-harmed for a really long time… It’s such an
awful thing… The further I got from it the better I was,
definitely.’ (Participant 05)
Some participants, like those cited above, stated that ‘quitting’ self-
harmwas their long-term goal and that reduction in frequency (how
often they were self-harming) could be a useful measure of progress
towards it. However, they were all quick to qualify this or add a ‘but’,
pointing out that the relationship between self-harm and mental
health was not straightforward and that it was wrong to assume
that less frequent is necessarily better. Likewise, measuring benefit
by means of reduction in frequency of hospital presentations was
seen as problematic, as was the use of standardised scales purporting
to measure depression and anxiety. We identified five cross-cutting
themes representing challenges to the validity and meaningfulness of
outcome measures currently used in self-harm trials, with two
Owens et al
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further themes relating to the context in which participants’ views were
framed. Figure 1 presents a visual representation of these findings.
Severity versus frequency
The issue of severity was raised repeatedly and was seen as being
in an inverse relationship to frequency: the more frequent the
self-harm, the less serious it was likely to be, and vice versa.
When discussing acts of self-harm, participants typically distin-
guished between ‘big ones’ (acts of violent or severe self-harm,
possibly with suicidal intent), which are less frequent but more
injurious, and ‘little ones’ (superficial wounds or small overdoses),
which are more frequent but less serious. They stressed that
frequency by itself meant nothing:
‘It could be that you’re doing it less often but it’s more severe,
and is that really an improvement? … Like, if it’s less frequent
and less severe, then that’s an improvement.’ (Participant 06)
One participant explained that the longer she resisted the urge to
self-harm the more the tension built up inside her, eventually
Table 1 Participant characteristics
Participant ID Age, years Gender Recruitment setting Interview mode Self-harm historya
01 24 Woman Hospital Face to face Presented following overdose
02 24 Man Community Face to face Presented at A&E with strong urge to self-harm and seeking advice
03 37 Woman Community Telephone History of self-harm, including overdose
04 30 Woman Community Telephone History of self-harm and frequent A&E attendance; no longer self-harming
05 29 Woman Community Telephone History of self-harm and frequent A&E attendance; no longer self-harming
06 19 Woman Community Telephone History of self-harm, including cutting and overdose
07 38 Man Hospital Telephone Presented following overdose; history of self-harm and eating disorder
08 23 Woman Community Telephone 10-year history of self-harm
09 22 Man Hospital Telephone Presented following overdose
10 22 Woman Hospital Telephone Presented following overdose
11 19 Woman Hospital Face to face Presented following overdose
12 Withheld Woman Hospital Telephone Presented following ingestion of toxic liquid
13 22 Woman Hospital Telephone Presented following overdose
14 27 Woman Community Face to face Frequent self-harm, including overdose
15 33 Woman Community Telephone 10-year history of self-harm, including overdose
16 46 Woman Community Telephone Frequent self-harm
17 27 Man Hospital Telephone Not recorded
18 23 Woman Community Email History of self-harm
A&E, accident and emergency.
a Details of hospital-recruited participants were supplied by the clinical team. Community-recruited participants were allowed to disclose as much or as little as they wished about their
self-harming history.
Perceived healthcare
rationing
(under resourcing of
services,leading to
competing for care)
Perceived healthcare
failures
(previous poor
experiences, leading to
avoidance of care)
Severity of self-harm
(less frequent may mean more severe; more
frequent/less severe may mean less visible)
Frequency of self-
harming behaviour
Frequency of hospital
(A&E) presentation
Scores on
depression/anxiety
scales
Current trial outcome
measures …
fail to take account of … within a context of … 
Behavioural substitution
(switching to less severe/less overt methods,
other maladaptive behaviours or alternative
services may reduce visibility)
Self-management of wounds
(increased skill in wound care results in fewer
A&E visits; reduces visibility)
Strategic self-presentation
(concealment versus display; needing to be
seen to be coping versus needing to be seen to
be struggling)
Self-harm as affect regulator/survival tool
(self-harm as protective, reduction risky;
produces false sense of wellness that may
skew scores)
Core theme
of VISIBILITY:
what aren’t
we seeing and
why not?
Fig. 1 Challenges to the validity of current outcome measures.
A&E, accident and emergency.
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resulting in a suicide attempt or major injury, and questioned
whether this meant that she was ‘better’ or ‘worse’ than someone
who gave in to their urges more frequently but inflicted less damage.
It was clear from participants’ accounts that not all acts of
self-harm are regarded as equal and that, if researchers are only
interested in counting episodes, there are questions as to what
‘counts’ – how serious an act needs to be and what methods
qualify for inclusion. Some suggested that they would not count
head-banging or biting, for example. Others were reluctant to
discount even the most minor forms of self-harm, stating that,
although they may not result in visible injury, they were still experi-
enced as troubling and were indicative of distress.
Severity of injury was also seen to have a bearing on frequency of
hospital visits, and therefore on the visibility of self-harm, as only
the ‘big ones’ were likely to require medical treatment. Thus, a
reduction in frequency of A&E visits might signify a reduction in
severity, but not necessarily in frequency of self-harm. One partici-
pant noted that the severest injuries were not always intentional:
‘The only time you’d go to hospital is if it was really severe. So
you’re not actually measuring when they’re self-harming,
you’re only measuring things like when they had an accident
and it got too deep.’ (Participant 07; our emphasis)
It was clear that severity of injury and need for medical attention
was a matter of individual judgement on each separate occasion,
and was always influenced by a number of factors, including previ-
ous experiences of treatment, feelings of shame and embarrassment,
and skill in self-management of wounds (see Self-management
skills). Perceived healthcare failures, including previous A&E treat-
ment that was experienced as hostile or punitive, were likely to result
in avoidance of hospital care.
Behavioural substitution
A closely related theme was that of substitution, or switching from
one type of behaviour to another. Nearly all participants stated that
a reduction in frequency of more typical behaviours, such as cutting
and overdosing, was by itself no indication of improvement.
Individuals may have switched to alternative methods, possibly
less overt and less likely to require medical treatment, or to other
equally maladaptive behaviours, such as excessive drinking or disor-
dered eating (bingeing or starvation). This again raised the question
of what ‘counts’ when counting instances of self-harm. Participants
stressed that researchers should pay closer attention to what people
are doing instead of self-harming, as alternative coping strategies
may be positive or negative:
‘So [a good outcome] would be utilising more positive coping
strategies.’ (Participant 03)
Positive coping strategies may include seeking help, which increases
the visibility of self-harm and thus may produce an apparent rise in
frequency, but this would be a misrepresentation of what is happen-
ing, suggesting a poorer rather than a better outcome.
Switching services may skew trial results in the opposite direc-
tion by reducing visibility. One participant noted that reduction in
A&E visits would be a false marker of progress for her because she
had been making more use of alternative services. The frequency
of her help-seeking had not reduced, but the fact that she was no
longer using statutory services might make it appear to have done so:
‘So instead of going to a proper hospital I go to the crisis house,
and tome that’s not really ameasure of success.’ (Participant 15)
Self-management skills
It was clear that some participants had become skilled in self-
administered wound care and that this, combined with other
factors such as shame and previous poor experiences of hospital
care, affected frequency of presentation at A&E:
‘As time goes on I go to hospital less frequently… . There are
times when I should go, but I’ve become better at dealing
with it myself, better at first aid, so I don’t feel the need.’
(Participant 06)
One participant explained that when she was younger she was ter-
rified by the idea of going to A&E and hardly ever did so, but that
she now regarded hospital avoidance as irresponsible. She explicitly
challenged the notion of reduction in hospital visits as an indicator
of progress, believing instead that getting proper hospital care repre-
sents good coping behaviour. Another participant, who had gone to
A&E seeking help to overcome a violent urge to self-harm, high-
lighted the role of A&E as a place of safety and means of self-
harm prevention. As noted above, the adoption of better coping
strategies, including seeking medical care, may have the paradoxical
effect of heightening visibility and thus suggesting that self-harm
has increased when in fact it may have decreased or stayed the same.
Self-harm as means of survival and affect regulator
Participants highlighted the function of self-harm as a means of sur-
vival, pointing out that some people self-harm in order to stay alive
and that, although stopping self-harming might appear to be a good
outcome, there were risks involved in relinquishing one’s survival
tool. As noted earlier, reducing the frequency of recurrent, minor
forms of self-harm may result in more extreme injury:
‘If it’s a habit and then you stop the habit, what happens in a
crisis time? Like, if they haven’t got that, do they just
completely slash their leg open?’ (Participant 11)
Another highlighted the function of self-harm as an affect regulator,
describing how it elevated her mood, masking symptoms of depres-
sion and giving her a false sense of wellness. She suggested that
self-report measures might capture that elation and interpret it as
improvement (and as attributable to a therapeutic intervention),
but that such an assessment would be wrong:
‘I felt like I was doing well in life because I had this way of
surviving, and [when] I was doing it I felt better and felt I
could live through the next day, and I wouldn’t have rated
myself as depressed at all… Now I look back and think, obvi-
ously I was so depressed that I needed that, but at the time
I thought, “I’m fine, I’m surviving”.’ (Participant 05)
Secrecy and strategic self-presentation
Secrecy emerged as a recurrent theme in participants’ accounts. The
practice of ‘keeping it hidden’ was seen to have a direct bearing on
the extent to which the frequency of both self-harming acts and self-
harm-related hospital visits could be reliably measured. Participants
noted that it was up to the individual to decide not only whether or
not to seek hospital treatment, but also whether or not to reveal the
self-inflicted nature of the injury when they do. They admitted both
to self-harming in secret and to being less than honest about it when
they were forced to seek medical care:
‘They [hospital staff] do ask you, “Have you self-harmed
before?” “No, of course not, these are some other sort of
injuries”.’ (Participant 01)
The issue of honesty also arose in relation to self-report question-
naires, typically measuring depression and anxiety, which are com-
monly used in research and clinical practice. Although some
participants defended the use of these, believing that plotting their
ups and downs over time could be helpful, others complained of
frustration or fatigue arising from their routine, uncritical use, par-
ticularly when mental distress was manifest. Nearly all participants
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commented that reliable measurement of mood is contingent upon
honesty, stating that how much they revealed about their mental
state could vary from one occasion to another and was determined
by their own overriding need or purpose at that time. They reported
responding strategically, both on questionnaires and in other clin-
ical contexts, either downplaying or exaggerating their distress in
order to achieve particular ends:
‘However honest I try to be, I feel like I end up manipulating
the result in one way or another, and a lot of people I speak
to feel the same.’ (Participant 02)
One participant described how she had been concealing her self-
harm and avoiding A&E for some time, for fear that she would be
stopped from going to university. While she needed to be seen to
be coping, others described needing to be seen to be struggling.
Either way, they were seeking to control how others perceived
them by reducing or increasing the visibility of their self-harm.
Within a context of scarce resources, high thresholds for clinical
care and perceived healthcare rationing, participants described
how they sometimes made a show of their self-harm, escalating its
severity and inflating their scores on depression/anxiety scales in
order either to win access to care or to prevent valued services
being withdrawn. This too was regarded as a means of survival:
‘You’d exaggerate it a bit just so people would take you a bit
more seriously… You want the help and… there are limited
places and obviously they’re going to give them to the ones
that are most in need.’ (Participant 09)
One participant gave a graphic account of how she had gambled
with her life, taking a huge and potentially lethal overdose, as a
result of which she was now receiving the highest level of mental
healthcare. While admitting the risk she had taken, she believed
that she had had no other option:
‘You feel like you have to prove how much you’re suffering…
I think I have to prove it in order to access services… because
no-one really takes any action until you’ve actually done some-
thing and then you get people really listening to you… It just
feels like actions speak so much louder than words.’
(Participant 15)
Other participants, also mindful of the scarcity of healthcare
resources, spoke of the need to use hospital time responsibly and
suggested that this might deter them from attending A&E.
Differences in the conceptualisation of outcomes and
measures
Participants did not find it easy to articulate what ‘improvement’
meant in relation to self-harming behaviour or how it should be
measured, and were often only able to answer after the question
had been posed several times in different ways. Even then, their
answers lacked clarity and seemed to conflate measures of improve-
ment with means of improvement. Although at first this appeared to
be a limitation of the data, closer analysis suggested that participants
were not actually confused but were conceptualising outcomes and
measures in a radically different way. Figure 2 presents a visual
representation of key differences, described in more detail below.
Indicators of improvement
We identified three broad areas of user-defined outcomes, all of
which focus on positive behaviours or achievements, rather than
simply on not self-harming.
General functioning or the ability to perform activities of daily
living and engage in normal self-care emerged strongly in partici-
pants’ accounts of what is important to them, and was regarded
as an indicator that things were getting better:
Interviewer: ‘So what’s a sign to you that things are going well
or that you’re improving?’
Conventional measures
focus on negatives
(what we should not do)
General functioning and activities of daily living
Desired outcome (a ‘good day’): get up, have a
shower, go to work, care for self and home
If I’m doing these things I know I’m doing well
(indicators of improvement)
Social participation
Desired outcome: see family and friends, be more
open and outgoing, pursue hobbies and interests
If I’m doing these things I know I’m doing well
(indicators of improvement)
Engagement with services
Desired outcome: go to therapy, take medication,
utilise services, ‘feel it’s OK to ask for help’
If I’m doing these things I know I’m doing well
(indicators of improvement)
If I’m doing these things I’m also
helping myself feel better
(means of improvement;
producing and/or reinforcing
positive outcomes)
User-defined measures focus on
positive behaviours
(what we can do)
User-defined measures are
also a means of sustaining
improvement 
… leaving a
BEHAVIOURAL VOID:
‘What are we supposed
to do instead?’
Frequency of self-
harming behaviour
Desired outcome: not
self-harming
Frequency of hospital
(A&E) presentation
Desired outcome: not
presenting at A&E
Fig. 2 Conventional versus user-defined outcome measures.
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Respondent: ‘For me it’s that the flat is tidy and that I’m at
work when I should be, I’m wearing clean clothes and I’m
washing every day and things like that… ‘cos they’re the
first things that fall through, aren’t they, if you’re not feeling
very well. For me anyway, like I’ll just not get out of bed…
I’ll overeat or I’ll just eat snacks and crisps and sweets and
stuff like instant foods… So that’s how I know I’m feeling
good.’ (Participant 11)
Social participation also featured prominently. Participants
characterised their bad times in terms of withdrawal and being
‘closed off’, whereas improvement was marked by being more
open and outgoing, seeing family and friends and pursuing
hobbies and interests. This was a sign of having more energy and
motivation, which was associated with ‘being in a good place’.
One participant noted that such activity is noticeable by others
and that asking close friends and relatives might sometimes be
more useful than relying on self-report measures:
‘It’s something that can be identified by someone close to you,
because I live with my mum and she often picks up on things
before I do… I tend to withdraw when I’m in a low mood, and
if I’m a bit more open and engaged that would be an indicator
that there is improvement.’ (Participant 08)
A third area of user-defined outcomes concerned engagement with
services. Several participants stated that proactively seeking health-
care or attending therapy sessions were signs of progress. These sig-
nified improving energy levels, as well as a commitment to recovery
and self-care. Participants reported that when they were unwell they
would miss appointments or fail to collect repeat prescriptions.
Being able to engage with services and adhere to medication was
therefore seen as a key marker of improvement. Some noted that
this was at odds with the thinking currently underpinning trials of
interventions for self-harm, in which not utilising hospital services
is seen as the positive outcome. Participants regarded this as deeply
puzzling:
‘I mean [people who self-harm] should be getting all the help
they can possibly get.’ (Participant 10)
Measure or means (or both)?
What was striking in the way participants talked about each of these
potential outcome domains was their tendency to slip from talking
about these things as measures of improvement into language that
implied they were also a means of improvement, and back again.
The following is an example:
‘When I was really unwell I just wouldn’t get up and go [to
therapy]… But actually when you look at my attendance
record, once I started going every single week I was getting
so much better. So I think engaging in services is quite a
good measurement… I guess it’s the same about medication
compliance… because when I picked up my repeat prescript
every month and saw my GP [general practitioner] and got
into that pattern of accepting help and taking my medicine,
I definitely improved… and that’s something that’s easy to
measure.’ (Participant 05)
The participant is saying that attendance and adherence are positive
outcomes in themselves and as such can be used as measures of
improvement (‘when I was really unwell I just wouldn’t get up
and go’), and at the same time that they are the means whereby
the improvement is achieved (‘when I got into that pattern of
taking my medicine, I definitely improved’).
Another participant, when asked how he would measure
improvement, or what kind of things might indicate to him that
he was doing better, talked about how he had found the courage
to go off travelling (indicator), and how he had come back a
‘completely different man’ (the activity itself had brought about
further positive change).
This suggests a more constructive way of thinking about
outcomes than has hitherto been seen. Conventional trial outcomes
are conceived as ends in themselves and, because they focus on not
self-harming and not returning to A&E, they leave a behavioural
void in which participants may well ask, ‘What are we supposed
to do instead?’ The user-defined outcomes proposed by our partici-
pants, on the other hand, take the form of activities and achieve-
ments, small practical triumphs that can be celebrated in
themselves, but which may in addition have an ongoing positive
effect and be a means of sustained improvement (Fig. 2).
Discussion
These frank interviews given by people who self-harm contain a
number of challenges to the validity of the main outcome measures
used in trials of interventions for this population, calling into ques-
tion both the logic behind the use of these measures and their
ability to capture what is actually happening. Our data suggest that
the use of these measures is based on a set of flawed assumptions,
namely that fewer recorded self-harm episodes, fewer visits to A&E
and improved scores onmood-rating scales reflect genuine improve-
ments in the lives and mental well-being of those who self-harm.
Our findings also draw attention to a complex array of extraneous
factors (severity of self-harm, behavioural substitution, self-manage-
ment of wounds, the affect-changing power of self-harm itself and
strategic self-presentation) that affect our ability to make accurate
measurements and may seriously confound trial results.
An observed reduction in either self-harm or A&E presentations
may mean a great many things. It may be a high-risk outcome, asso-
ciated with increased likelihood of severe injury or suicide, and it
may be illusory, merely reflecting a reduction in the visibility of
certain behaviours. Conversely, an observed increase, particularly
in A&E visits, may not be the negative outcome we assume it to
be. It may signify less concealment, less service avoidance and
increased willingness to accept help, which participants regard as
positive signs. This highlights the seemingly perverse logic of self-
harm trials, which appear, at least to some participants, to be
intent on keeping people out of services that are designed to help
them. Although understandable in view of the pressure to demon-
strate healthcare cost savings, the high value accorded in self-
harm trials to reducing hospital visits conflicts with a wider public
health discourse that seeks to encourage help-seeking. It may also
perpetuate among vulnerable individuals the perception of health-
care rationing, which, as our data show, can drive them to desperate
lengths, risking their lives in order to prove their need.
Health behaviours pose special challenges for outcome meas-
urement because of the complex functions they perform for those
who engage in them, the invisible motivational pathways that give
rise to them, and the often hidden nature of the behaviours
themselves. They differ in these respects from physical diseases, in
which signs and symptoms are involuntary and observable.
Our study shows not only the extent to which those who engage
in troubling health behaviours are able to control what others see
and quantify, but also provides reasons why they may sometimes
conceal and at other times display both the behaviours and the
underlying cognitive–emotional states.
These findings fit with Nock’s distinction between the intraper-
sonal (affect-regulating) and interpersonal (communicative) func-
tions of self-harm, the former being more likely to be associated
with concealment and the latter involving visible display.25 They
also both confirm and augment Geulayov and colleagues’ sugges-
tion of a ‘tip of the iceberg’ situation with regard to self-harm.6
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Geulayov et al distinguish between overt (fatal and hospital-present-
ing) and covert (community-occurring) self-harm and demonstrate
the extent to which this limits our ability to measure overall
incidence. Our findings show that our ability to measure trial out-
comes is also limited to those acts and affects that participants
allow us to see – those they choose for their own reasons, including
self-preservation, to render visible.
Implications for future research and intervention
development
The randomised controlled trial is the gold-standard design for
evaluating healthcare interventions. However, our study highlights
a number of fundamental tensions between trial science and the
lived experience of people who self-harm.
Randomised controlled trials are predicated on a ‘paradigm of
order’, in which variables are controllable and effects predictable.26
Behaviours such as self-harm are complex, disorderly and unpre-
dictable, although close examination may reveal that they possess
a logic all of their own. Our findings certainly suggest, as do other
qualitative studies,9 that people who self-harm have very cogent
reasons for behaving in the ways they do and very clear personal
goals, but these are not well aligned with conventional trial out-
comes. Nor are they necessarily amenable to measurement using
standardised means, because of their sometimes personal and
idiosyncratic nature.
The answer is not to abandon trials but to recognise their prob-
lematic nature and to mitigate the risk of spurious or misleading
results. This can be done in a number of ways. The first is to incorp-
orate thoroughgoing process evaluation, using in-depth qualitative
methods to tease out what is really happening and what any
observed effects might mean. The second is to conduct robust
patient and public involvement at the very earliest stage of trial
design to ensure the inclusion of outcomes that are relevant and
meaningful to those who self-harm. This may also help to
improve recruitment rates and reduce respondent burden. The
development of a core outcome set for self-harm trials remains a
long-term goal. It is beyond the scope of this article to describe
the core outcome set development process, which is well-documen-
ted elsewhere,17 but the present study suggests that achieving
consensus between different stakeholder groups (clinicians,
researchers and people who self-harm) will not be easy.
Meanwhile, intervention developers should focus on under-
standing and targeting user-defined outcomes. By doing so, we
may be able to move from quick ‘fixes’ that may look promising
but leave a dangerous behavioural void to providing people with
the means to make tangible changes in their everyday lives,
thereby sustaining positive effects and contributing to their own
ongoing recovery.
Limitations of the study
Our sample was small and drawn from one English provincial city.
We collected limited data on demographics, number of self-harm
episodes or motivation for self-harming, and did not distinguish
between self-harm with intent to die and non-suicidal self-injury.
The discussion of outcomes formed only one part of a longer
interview covering other trial-related issues, including recruitment
practices. Participants found it conceptually challenging and some
of them struggled to formulate their thoughts, particularly about
what outcomes were important to them. We recognise that we
may not have fully captured their views and that further in-depth
work is needed. Nonetheless, to our knowledge this is the first
study to investigate what people with histories of self-harm think
about trial outcomes, and it provides further valuable insight into
their everyday worlds.
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